Ovid Therapeutics Inc. (OVID) Free cash flow 2016–2025
Ovid Therapeutics Inc. (OVID) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$38.3MFY2025 · since FY2016: -$17.8M → -$38.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.3M | +31.6% |
| FY2024 | -$56.0M | -22.3% |
| FY2023 | -$45.8M | +18.8% |
| FY2022 | -$56.5M | -147.7% |
| FY2021 | $118.4M | +329.0% |
| FY2020 | -$51.7M | -1.1% |
| FY2019 | -$51.1M | -12.2% |
| FY2018 | -$45.6M | -44.7% |
| FY2017 | -$31.5M | -76.7% |
| FY2016 | -$17.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OVID financial trends
OVID RevenueOVID Net incomeOVID Net marginOVID Gross profitOVID Gross marginOVID Operating incomeOVID Operating marginOVID Operating cash flowOVID Capital expendituresOVID Return on equityOVID Stock buybacksOVID Dividends paidOVID Total assetsOVID Total liabilitiesOVID Shareholders’ equityOVID overview →